GG Ventures has raised $30 million in a first close of its new fund, targeting a final close of $100 million to invest in AI-native healthtech companies focused on female performance across sports, longevity, and wellness.
The UK-based investment platform targets companies from growth seed to Series A stage across five key areas: Sports and wellness, next-generation productivity, longevity and chronic diseases, seven female cancers, and mental health and cognitive performance.
“This is the decade of female performance and we’re not waiting for permission,” said Priya Oberoi-Cattell, Founding General Partner. “We’re building with athletes, scientists, founders, and iconoclasts who aren’t just challenging legacy systems they are re-designing and re-writing it.”
Founded in 2021, GG Ventures positions itself as a venture platform dedicated to female performance optimization. The fund targets what the firm calls “AI-native healthtech” companies that leverage cultural momentum around women’s sports and performance.
